NCT02121665View on ClinicalTrials.gov

Efficacy of a Probiotic Lozenges in Chronic Periodontitis Patients.

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

March 31, 2016

Conditions
Chronic Periodontitis
Interventions
DRUG

Probiotic (Inersan)

Each Inersan lozenge contains not less than 1 billion CFU of Lactobacillus brevis CD2

DRUG

Placebo

Each placebo lozenge contains all excipients except the active constituent (Lactobacillus brevis CD2)

Trial Locations (1)

415570

Department of Periodontics, Government Dental College & Hospital, Aurangabad

All Listed Sponsors
collaborator

Government Dental College and Hospital, India

OTHER_GOV

lead

CD Pharma India Pvt. Ltd.

INDUSTRY

NCT02121665 - Efficacy of a Probiotic Lozenges in Chronic Periodontitis Patients. | Biotech Hunter | Biotech Hunter